Close
Help




JOURNAL

Clinical Medicine Insights: Therapeutics

Novel Agents and Emerging Treatment Strategies in Multiple Sclerosis. What Role for Cladribine?

Submit a Paper


Clinical Medicine Insights: Therapeutics 2011:3 425-439

Review

Published on 06 Oct 2011

DOI: 10.4137/CMT.S6456


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Therapeutics

Abstract

Multiple sclerosis (MS), a chronic inflammatory-degenerative illness of the central nervous system (CNS), remains at the moment a treatable but incurable disease. Currently available disease-modifying agents (DMA-s), the majority of which are being injected, mainly relieve the inflammatory phase of MS with little beneficial effect, if any, in halting neurodegeneration. Cladribine is an immunosuppressive agent that can be administered orally and by cycles of short-course dosing as opposed to continuous administration. Cladribine has been shown to be effective in reducing inflammatory activity of MS but much remains unknown regarding its potential beyond the control of CNS inflammation. In addition, knowledge on the safety profile of cladribine in MS is limited. Data from on going clinical studies and registries on its safety profile will shed more light on the actual benefit/risk ratio of cladribine.



Downloads

PDF  (649.76 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)




What Your Colleagues Say About Clinical Medicine Insights: Therapeutics
My submission to Libertas was one of the easiest and most time-efficient publication processes I have come across.  From the quick response of the reviewers to the rapid return of the proofs, I was amazed at how quickly my article was "publication ready"!  Thanks for such a painless publication process.
Dr Gerald W Dryden MD (University of Louisville, Louisville, Kentucky, USA)
More Testimonials

Quick Links


New article and journal news notification services